Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling-Reference-Cited by-同舟云学术

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling

Published:2017-10-31 Issue:57 Volume:8 Page:97516-97527
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kuusanmäki Heikki¹²,Dufva Olli²,Parri Elina¹,van Adrichem Arjan J.¹,Rajala Hanna²,Majumder Muntasir M.¹,Yadav Bhagwan¹,Parsons Alun¹,Chan Wing C.³,Wennerberg Krister¹,Mustjoki Satu²⁴,Heckman Caroline A.¹

Affiliation:

1. Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland

2. Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

3. Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA

4. Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders;Blood Cancer Journal;2024-01-18

2. Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing;Biomedicine & Pharmacotherapy;2023-11

3. Strategies for Targeting the JAK ‐ STAT Pathway in Lymphoid Malignancies;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

4. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma;Cancers;2023-02-21

5. High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls;PLOS ONE;2022-11-28